首页> 外文OA文献 >Association of the CASQ1 gene SNP rs3838216 with Graves' ophthalmopathy and Hashimoto’s thyroiditis in patients with thyroid autoimmunity
【2h】

Association of the CASQ1 gene SNP rs3838216 with Graves' ophthalmopathy and Hashimoto’s thyroiditis in patients with thyroid autoimmunity

机译:甲状腺自身免疫性疾病中CASQ1基因SNP rs3838216与Graves眼病和桥本甲状腺炎的关系

摘要

The pathogenesis of Graves' ophthalmopathy is poorly understood, but there is evidence for the involvement of calsequestrin (CASQ1) as an autoantigen. Aim: To compare the frequency of the single nucleotide polymorphism (SNP) rs3838216 (located in intron 1 of CASQ1) in patients with autoimmune thyroid disease (ATD), Graves' Ophthalmopathy and controls. Methods: Germline DNA was assayed for rs3838216 by MassARRAY SNP analysis using iPLEX technology of SEQUENOM in 405 individuals (98 males, 307 females) with ATD (comprising Graves' Opthalmopathy (GO, N=74), Graves' Hyperthyroidism (GH, N=131), Hashimoto's thyroiditis (HT, N=92), and controls with no personal or family history of autoimmune thyroid disorders (N=108). Results: Genotypes for rs3838216 differed significantly across groups with minor allele frequencies as follows: GO 17%, GH 24%, HT 19% and controls 30% groups (P=0.0427). P of SNP rs3838216 was significant in GO vs. control (odds ratio 2.16, P=0.003), and HT vs control (odds ratio 1.87, P= 0.008). On pair wise analysis, homozygosity for the major allele was associated with GO vs. control (odds ratio = 2.42, P=0.0046), and HT vs control (odds ratio 2.07, P=0.0116); whereas heterozygosity was associated with GO vs. control (odds ratio = 0.52, P=0.039), and HT vs control (odds ratio 0.570, P=0.054). Conclusion: The CASQ1 gene SNP rs3838216 is associated with autoimmune thyroid disease and with GO in particular.
机译:格雷夫斯眼病的发病机理知之甚少,但有证据表明钙调蛋白(CASQ1)作为自身抗原参与其中。目的:比较患有自身免疫性甲状腺疾病(ATD),Graves眼病和对照的患者的单核苷酸多态性(SNP)rs3838216(位于CASQ1内含子1)的频率。方法:采用iQUESE iPLEX技术,通过MassARRAY SNP分析,采用SEQUENOM iPLEX技术对405例ATD(包括格雷夫斯眼病(GO,N = 74),格雷夫斯甲状腺功能亢进症(GH,N =)的个体进行了rs3838216分析。 131),桥本氏甲状腺炎(HT,N = 92)和无自身免疫性甲状腺疾病的个人或家族病史的对照组(N = 108)。结果:rs3838216的基因型在等位基因频率较低的人群中差异显着,如下所示:GO 17% ,GH 24%,HT 19%和对照组30%组(P = 0.0427)。SNP rs3838216的P在GO与对照组(赔率2.16,P = 0.003)和HT与对照组(赔率1.87,P = 0.008)。在成对分析中,主要等位基因的纯合性与GO与对照(比值比= 2.42,P = 0.0046)和HT与对照(比值比2.07,P = 0.0116)相关;而杂合性则与结论:CASQ1基因与GO相对于对照(比值= 0.52,P = 0.039)和HT相对于对照(比值0.570,P = 0.054)有关。 SNP rs3838216与自身免疫性甲状腺疾病有关,尤其与GO有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号